Form Health

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Nearby Clinics

Boston, MA

Peptides & Treatments

About

Form Health operates as a telehealth-focused obesity medicine practice serving patients throughout Massachusetts from its Boston headquarters, established in 2019 with board certification from the American Board of Obesity Medicine. The clinic delivers structured weight loss programs that combine GLP-1 receptor agonist medications with ongoing clinical oversight, specifically utilizing semaglutide, tirzepatide, and liraglutide as pharmaceutical interventions for patients meeting clinical criteria for obesity treatment. Each patient works with an assigned Care Team that includes prescribing clinicians credentialed in obesity medicine alongside registered dietitians who provide nutrition counseling tailored to individual metabolic profiles and lifestyle factors.

The medication protocols at Form Health center on incremental dosing strategies for GLP-1 therapies, with semaglutide and tirzepatide representing the primary peptide options for appetite regulation and glycemic control in eligible patients. Liraglutide serves as an alternative GLP-1 agonist for patients who require different dosing flexibility or have specific contraindications to the other medications. Clinical staff evaluate patients through comprehensive intake assessments that review medical history, current medications, weight loss goals, and any contraindications before prescribing these peptide therapies. The Boston-based medical team monitors patient progress through regular check-ins via the clinic's digital platform, adjusting medication dosages based on tolerance, side effect profiles, and weight loss trajectory over the treatment course.

Form Health's clinicians hold credentials in obesity medicine and maintain active licenses to prescribe controlled medications across state lines where telehealth regulations permit, with the Massachusetts-based practice serving as the administrative hub for clinical operations. The dietitians on staff provide evidence-based nutritional guidance that addresses macronutrient distribution, meal timing, and behavioral strategies to support the physiological effects of GLP-1 medications. This dual-provider model distinguishes the practice from single-clinician approaches, as patients receive both pharmacological management and nutritional counseling as integrated components of their treatment plan rather than as separate services.

Patients access Form Health entirely through telehealth appointments and a proprietary mobile application that facilitates messaging with care team members, tracks weight measurements, logs food intake, and provides educational resources about obesity pharmacotherapy. The digital-first model eliminates geographic barriers for Massachusetts residents seeking obesity medicine specialists, with video consultations replacing traditional in-office visits for medication management and progress evaluations. Prescription fulfillment occurs through partner pharmacies that ship medications directly to patients, with the care team coordinating insurance verification and prior authorization processes when applicable. The messaging system within the app allows patients to report side effects, ask questions about medication administration, or request guidance on nutrition challenges between scheduled appointments.

The clinic's approach to accountability involves scheduled weigh-ins, regular dietitian consultations, and clinician reviews at protocol-defined intervals throughout the treatment program. Form Health structures its programs around multi-month commitments that align with the timeline required for GLP-1 medications to demonstrate clinical efficacy, typically involving initial titration phases followed by maintenance dosing periods. The Boston practice emphasizes the role of these peptide therapies as tools within a broader obesity management strategy rather than standalone solutions, incorporating behavioral modification support and nutritional education as essential program elements that continue throughout the patient's enrollment.

Care Team

· American Board of Obesity Medicine certified physician

Topics Mentioned in Reviews

Patient Reviews

Pricing

Monthly program: 299

FAQ

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Key takeaways

VIP mold illness describes persistent vasoactive intestinal peptide suppression triggered by biotoxin exposure in genetically susceptible individuals with HLA-DR gene variants that impair toxin clearance.
Elevated TGF-beta-1 and MMP-9 from chronic biotoxin exposure downregulate VIP receptors and neuropeptide production, creating a self-perpetuating inflammatory cascade independent of ongoing mold contact.
Intranasal VIP replacement therapy at 50 mcg four times daily has shown 75–80% symptom improvement in clinical observations, but only after environmental remediation, binder therapy, and MARCoNS eradication.
VIP has a 2-minute half-life in circulation, requiring frequent dosing and strict storage at 2–8°C to maintain peptide integrity and therapeutic activity.
CIRS involves multi-system dysregulation beyond VIP deficiency, including complement activation (elevated C4a), MSH suppression, leptin resistance, and blood-brain barrier disruption from MMP-9 elevation.
Research-grade VIP peptides enable investigation of immune cell phenotype shifts, cytokine regulation, and neuroprotective mechanisms in laboratory models of biotoxin-induced inflammation.

realpeptides.co

Inflammation reduction versus fat reduction: which matters more?

This is the question that the Italian exenatide study highlighted so powerfully. Case 1 lost no weight but still experienced pain reduction and measurable changes in subcutaneous fat thickn…

Source: seekpeptides.com

comparison

Keto supplements versus GLP-1 medications: they are not the same thing

This distinction requires absolute clarity because confusion here can be dangerous. Exogenous ketone supplements, MCT oil products, and "keto pills" sold over the counter are NOT GLP-1 rece…

Source: seekpeptides.com

Research context

Read sources and limitations before applying a claim.

Off-Label, Yet Evidence-Based Use

"Off-label" means a drug is used for a purpose not specifically approved by the FDA. Some peptides fall into this category with growing evidence: BPC-157• Studied for tendon and ligament healing in animal models• Human data still limited—some sports medicine doctors use it off-label for injury recovery Thymosin Beta-4• Examined for wound healing and tissue repair• Early small studies suggest potential, but larger trials are needed Physicians who prescribe off-label peptides typically: Review up-to-date clinical literature Monitor patients closely for side effects Obtain informed consent explaining uncertainties

Source: ubiehealth.com ↗

What the Research Says

While peptide therapy is still an emerging field, several high-quality studies support its potential: BPC-157: Animal studies and early human trials show accelerated healing of tendons, ligaments, and gut lining. Thymosin Alpha-1 (Tα1): Shown to enhance immune response in viral infections and improve vaccine efficacy. CJC-1295 & Ipamorelin: Commonly used for growth hormone stimulation, these peptides have been linked to increased lean muscle mass, reduced body fat, and improved sleep quality. PT-141 (Bremelanotide): FDA-approved for female sexual dysfunction, illustrating that peptides can pass rigorous regulatory hurdles. It's important to note that while some peptides have robust clinical data and regulatory approval, others are still under investigation. Always consult a qualified healthcare provider before starting any new therapy.

Source: ubiehealth.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosage

The recommended PT-141 dosage varies depending on the person. Many start with 0.5 milligrams (mg). Others require up to 2 mg for effects to work. It may involve some trial and error before you find a suitable amount. Bremelanotide usually kicks in around an hour after injecting it. Don’t use more than one injection per 24 hours.

Source: livvnatural.com ↗

Potential benefits

What Are the Benefits of Peptide Therapy in Tucson, AZ?

Peptide therapy offers a multitude of benefits that can significantly impact various aspects of health and wellness. Some of the key advantages include: Enhanced Muscle Growth and Recovery: Peptides like BPC-157 and CJC-1295 are known for their ability to promote muscle growth, improve strength, and accelerate recovery from injuries. Improved Skin Health: Peptides such as GHK-Cu can stimulate collagen production, leading to firmer, more youthful-looking skin. Boosted Immune Function: Thymosin Alpha-1 is a peptide that can enhance immune system function, making the body more resilient to infections and illnesses. Weight Management: Peptides like AOD-9604 can aid in fat loss and improve metabolism, assisting in weight management goals. Cognitive Enhancement: Certain peptides can improve cognitive function, memory, and focus, contributing to better mental clarity and performance. Hormonal Balance: Peptide therapy can help regulate hormone levels, addressing issues such as low libido, fatigue, and mood swings.

Source: nulevelwellnessmedspa.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →